International Journal of Clinical Research

Objective During the treatment of patients with severe pneumonia caused by phlegm-heat congestion in the lungs accompanied by cough, Xuanbai Chengqi Decoction was administered to analyze its clinical impact on cough relief and safety. Methods From January 2023 to January 2025, 60 patients with severe pneumonia and cough caused by phlegm-heat congestion in the lungs in our hospital were included in the study. They were divided into two groups (control group and observation group) in a 1:1 ratio and received differentiated treatment plans. After distinguishing the groups, conventional Western medical treatment (control group) and Xuanbai Chengqi Decoction as an adjunctive treatment (observation group) were carried out. Summarize the therapeutic effects of the two groups. Results In terms of intervention effectiveness, the total effective rate of treatment in the observation group reached 90.00%, which was significantly higher than that of the control group (70.00%), as analyzed statistically (P<0.05). For the improvement of core symptoms, the cough relief effect of the observation group was also better than that of the control group (P<0.05). In terms of medication safety, the occurrence of adverse reactions was similar in the two groups (P>0.05). Conclusion Xuanbai Chengqi Decoction as an adjunctive treatment for patients with severe pneumonia can improve the clinical efficacy and cough relief rate, and has good safety.

Xuanbai Chengqi decoction; Severe pneumonia; Clinical efficacy